P. Shukla

发表

DNA damage repair and cardiovascular diseases.

S. Verma, B. Yanagawa, P. Shukla, 2010, The Canadian journal of cardiology.

Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages.

M. Al-Omran, S. Verma, Y. Pan, 2010, American journal of physiology. Heart and circulatory physiology.

BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis

M. Al-Omran, H. Leong-Poi, P. Shukla, 2012, Gene Therapy.

The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis

S. Blankenberg, S. Heymans, C. Scheibenbogen, 2018, European heart journal.

The Second Conversation project: Improving training in end of life care communication among junior doctors

R. Schiff, P. Shukla, P. Leonard, 2019, Future Healthcare Journal.

Sequence variations in the 5′ upstream regions of the FBN1 gene associated with Marfan syndrome

K. Rommel, J. Schmidtke, P. Shukla, 2006, European Journal of Human Genetics.

Inadvertent nucleotide sequence alterations during mutagenesis: highlighting the vulnerabilities in mouse transgenic technology

P. Shukla, Rituparna Chakrabarti, Anuran Ghosh, 2021, Journal of Genetic Engineering and Biotechnology.

Glutathione Adducts on Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Cys-674 Regulate Endothelial Cell Calcium Stores and Angiogenic Function as Well as Promote Ischemic Blood Flow Recovery*

R. Weisbrod, R. Cohen, P. Shukla, 2014, The Journal of Biological Chemistry.

Exploring the crosstalk between long non-coding RNAs and microRNAs to unravel potential prognostic and therapeutic biomarkers in β-thalassemia

P. Shukla, Motiur Rahaman, T. Dolai, 2022, Molecular Biology Reports.

Effects on duration of post-operative ischemia and patterns of blood flow recovery in different conditions of mouse hind limb ischemia

C. Napoli, M. Al-Omran, S. Verma, 2011, Vascular cell.

Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.

S. Verma, Y. Pan, B. Yanagawa, 2013, The Journal of thoracic and cardiovascular surgery.

BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure*

Michael D. Schneider, M. Al-Omran, S. Verma, 2011, The Journal of Biological Chemistry.

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

Arthur S Slutsky, M. Al-Omran, S. Verma, 2008, American journal of physiology. Heart and circulatory physiology.

Continuous Glycoprotein-130-Mediated Signal Transducer and Activator of Transcription-3 Activation Promotes Inflammation, Left Ventricular Rupture, and Adverse Outcome in Subacute Myocardial Infarction

H. Drexler, Werner Müller, D. Hilfiker-Kleiner, 2010, Circulation.

Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.

M. Al-Omran, S. Verma, Y. Pan, 2009, American journal of physiology. Endocrinology and metabolism.

Apixaban for stroke prevention in a patient with a mechanical heart valve.

P. Shukla, Prasanna Aghoram, I. Ashraf, 2018, British journal of hospital medicine.

Conservation of 5′-upstream region of the FBN1 gene in primates

P. Shukla, K. Singh, J. Schmidtke, 2008, European Journal of Human Genetics.

Idiopathic aortitis presenting as pyrexia of unknown origin and delirium.

D. D'cruz, P. Shukla, A. Bhalla, 2018, British journal of hospital medicine.

Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies

P. Shukla, Motiur Rahaman, S. Ray, 2021, Molecular Biology Reports.

Abstract 14465: Loss of BRCA2 in the Heart Induces Age-Related Cardiomyopathy

M. Al-Omran, S. Verma, W. Stanford, 2012 .

BRCA1 is an essential regulator of heart function and survival following myocardial infarction

Michael D. Schneider, William L. Stanford, Adrian Quan, 2011, Nature communications.

Adropin Is a Novel Regulator of Endothelial Function

M. Al-Omran, S. Verma, P. Shukla, 2010, Circulation.

Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer.

K. Chaudhury, P. Shukla, Anindita Bhattacharya, 2021, Biochimica et biophysica acta. Reviews on cancer.

Debunking the “junk”: Unraveling the role of lncRNA–miRNA–mRNA networks in fetal hemoglobin regulation

P. Shukla, Motiur Rahaman, Prasanna Kumar Byram, 2021, bioRxiv.

BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.

M. Al-Omran, S. Verma, W. Stanford, 2013, The Journal of thoracic and cardiovascular surgery.

Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology

P. Shukla, Rituparna Chakrabarti, Anuran Ghosh, 2020, Frontiers in Genetics.

miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis.

S. Verma, B. Yanagawa, P. Shukla, 2012, The Journal of thoracic and cardiovascular surgery.

MicroRNA-145 Targeted Therapy Reduces Atherosclerosis

M. Al-Omran, S. Verma, P. Marsden, 2012, Circulation.

Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death.

M. Al-Omran, S. Verma, H. Leong-Poi, 2011, Biochemical and biophysical research communications.

Increased Collagen Deposition and Diastolic Dysfunction but Preserved Myocardial Hypertrophy After Pressure Overload in Mice Lacking PKC&egr;

H. Drexler, M. Leitges, D. Hilfiker-Kleiner, 2005, Circulation research.

Natural Killer T cells and the invariant subset promote atherosclerosis: A meta-analysis.

P. Shukla, N. Chakravorty, Rituparna Chakrabarti, 2023, Life sciences.

, ε Hypertrophy After Pressure Overload in Mice Lacking PKC Increased Collagen Deposition and Diastolic Dysfunction but Preserved Myocardial

H. Drexler, M. Leitges, D. Hilfiker-Kleiner, 2005 .

Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review

P. Shukla, Motiur Rahaman, T. Dolai, 2023, Thalassemia Reports.